Infectious Disease Clinics of North America
Overview
Infectious Disease Clinics of North America is a peer-reviewed medical journal that focuses on the latest research and clinical advancements in the field of infectious diseases. It provides comprehensive reviews and expert perspectives on various topics, including emerging infections, antimicrobial therapy, immunizations, and epidemiology. The journal serves as a valuable resource for healthcare professionals, researchers, and policymakers seeking to stay updated on the prevention, diagnosis, and treatment of infectious diseases in North America.
Details
Details
Abbr.
Infect Dis Clin North Am
Start
1987
End
Continuing
Frequency
Quarterly
p-ISSN
0891-5520
e-ISSN
1557-9824
Country
United States
Language
English
Specialty
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 2409
115
SJR / Ranks: 2290
1360
CiteScore / Ranks: 1055
11.50
JIF / Ranks: 1945
4.4
Recent Articles
1.
Alrubayyi A, Huang H, Gaiha G
Infect Dis Clin North Am
. 2025 Mar;
PMID: 40089444
The humoral and cellular immune response are the key players in preventing viral infection and limiting disease severity, particular in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
2.
Shumaker A, Bhimraj A
Infect Dis Clin North Am
. 2025 Mar;
PMID: 40089443
Widespread vaccination, hybrid immunity, and reduced pathogenicity with circulating Omicron variants have decreased the rate of severe coronavirus disease 2019 (COVID-19) outcomes in the general population. Certain patients with COVID-19...
3.
Shaffer A, Meyerowitz E
Infect Dis Clin North Am
. 2025 Mar;
PMID: 40068975
While most SARS-CoV-2 infections and reinfections in the era of widespread population immunity with omicron subsub-lineage variants are mild for immunocompetent individuals, any manifestation previously seen during the pandemic phase...
4.
Emery I, Rosen C
Infect Dis Clin North Am
. 2025 Mar;
PMID: 40068974
Long coronavirus disease 2019 (COVID-19) is a multisystem disorder with variable manifestations and duration. One in 10 people with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection will develop...
5.
Pinkney J
Infect Dis Clin North Am
. 2025 Mar;
PMID: 40068973
The COVID-19 pandemic unmasked striking health disparities within the US healthcare system and significantly impacted vulnerable populations. While much attention on vulnerability has been directed toward older individuals with underlying...
6.
7.
Alsoubani M, Chow J
Infect Dis Clin North Am
. 2025 Mar;
PMID: 40055107
The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted immunocompromised hosts, leading to higher morbidity and mortality. The clinical outcomes have varied based on the degree of immunosuppression, treatment availability,...
8.
Donovan F, Ampel N, Thompson 3rd G
Infect Dis Clin North Am
. 2024 Dec;
39(1):183-197.
PMID: 39710556
Coccidioidomycosis is the clinical disease caused by the dimorphic pathogenic fungi Coccidioides immitis and C posadasii. The number of clinically recognized coccidioidomycosis cases continues to increase yearly including in regions...
9.
Jani A, Reigler A, Leal Jr S, McCarty T
Infect Dis Clin North Am
. 2024 Dec;
39(1):199-219.
PMID: 39710555
Cryptococcosis is an invasive fungal infection caused by yeasts of the genus Cryptococcus that causes a significant global burden of disease in both immunocompromised and immunocompetent individuals. Over the past...
10.
Schroeder J, Wilson C, Pappas P
Infect Dis Clin North Am
. 2024 Dec;
39(1):93-119.
PMID: 39706747
Invasive candidiasis (IC) is a term that refers to a group of infectious syndromes caused by a variety of Candida species, 6 of which cause the vast majority of cases...